CYP1B1 Mediates Cigarette Smoke–Induced Lipid Accumulation in Alveolar Type 2 Cells
The FASEB Journal · 2025
DOI: 10.1096/fj.202501439rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Yin Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP1B1, Alveolar Epithelial Cells, Lipid Metabolism, Smoke. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Georgia Clinical and Translational Science Alliance (CTSA), HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), NCATS NIH HHS.
Abstract (Originalsprache)
Alterations in lipid profiles have been shown in patients with chronic obstructive pulmonary disease (COPD), but the underlying molecular mechanisms remain unclear. In this study, we aimed to investigate the role of cytochrome P450 family‐1 subfamily B member 1 (CYP1B1) in cigarette smoke (CS)‐induced lipid accumulation in alveolar type II epithelial (AT2) cells. We observed a steady increase in CYP1B1 protein levels in AT2 cells from COPD patients. Additionally, CS exposure induced CYP1B1 expression in AT2 cells of murine lungs. In vitro, treatment with cigarette smoke extract (CSE) not only upregulated CYP1B1 expression but also triggered lipid accumulation in AT2‐like cells. Functionally, overexpression of CYP1B1 promoted lipid accumulation in A549 and MLE‐12 cells. Consistently, siRNA‐mediated CYP1B1 inhibition significantly reduced CSE‐induced lipid accumulation in AT2‐like cells. Furthermore, treatment with 2,3′,4,5′‐tetramethoxystilbene (TMS), a selective CYP1B1 inhibitor, reduced CSE‐induced lipid accumulation. TMS also attenuated CSE‐induced mitochondrial reactive oxygen species production and cell apoptosis. Taken together, our findings suggest that CYP1B1 is upregulated by CS exposure and plays a key role in CS‐induced lipid accumulation in AT2 cells. Targeting CYP1B1 may offer a potential therapeutic strategy for addressing lipid dysregulation and lung pathology in patients with COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, Georgia, USA.
- Charlie Norwood VA Medical Center, Augusta, Georgia, USA.
- Baylor College of Medicine, Medicine, Houston, Texas, USA.
- Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia, USA.
ORCID-Profile: Duo Zhang
Förderung
- Georgia Clinical and Translational Science Alliance (CTSA)
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- NCATS NIH HHS
- NHLBI NIH HHS
- American Heart Association (AHA)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Zhu, Y., Gamare, S., Polverino, F., Owen, C. A., Somanath, P. R., Wang, X., & Zhang, D. (2025). CYP1B1 Mediates Cigarette Smoke–Induced Lipid Accumulation in Alveolar Type 2 Cells. The FASEB Journal. https://doi.org/10.1096/fj.202501439rr
Vancouver
Zhu Y, Gamare S, Polverino F, Owen CA, Somanath PR, Wang X, et al. CYP1B1 Mediates Cigarette Smoke–Induced Lipid Accumulation in Alveolar Type 2 Cells. The FASEB Journal. 2025. doi:10.1096/fj.202501439rr
BibTeX
@article{Zhu2025,
author = {Zhu, Yin and Gamare, Siddhika and Polverino, Francesca and Owen, Caroline A and Somanath, Payaningal R and Wang, Xiaoyun and Zhang, Duo},
title = {CYP1B1 Mediates Cigarette Smoke–Induced Lipid Accumulation in Alveolar Type 2 Cells},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202501439rr}
}
EUVIMED